Related references
Note: Only part of the references are listed.Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients
Shiwei Guo et al.
BRITISH JOURNAL OF CANCER (2020)
Refined TNM-staging for pancreatic adenocarcinoma - Real progress or much ado about nothing?
Marcus Roalso et al.
EJSO (2020)
Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
Jordan M. Cloyd et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Prognostic potential of the preoperative plasma complement factor B in resected pancreatic cancer: A pilot study
Sung Hyun Kim et al.
CANCER BIOMARKERS (2019)
Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients
Keisuke Taniuchi et al.
PLOS ONE (2019)
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
Jin G. Choi et al.
ONCOLOGIST (2019)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies Where Are We?
Robert A. Wolff
SURGICAL CLINICS OF NORTH AMERICA (2018)
Measurement of serum PODXL concentration for detection of pancreatic cancer
Keisuke Taniuchi et al.
ONCOTARGETS AND THERAPY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society A Synopsis
Koji Yamaguchi et al.
PANCREAS (2017)
Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
Keisuke Taniuchi et al.
CANCER SCIENCE (2016)
Pancreatic cancer: yesterday, today and tomorrow
Daniel Ansari et al.
FUTURE ONCOLOGY (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells
Makiko Tsuboi et al.
PANCREATOLOGY (2016)
Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging
Olca Basturk et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study
Frank Weilert et al.
GASTROINTESTINAL ENDOSCOPY (2014)
Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Maximilian Bockhorn et al.
SURGERY (2014)
Influence of Perineural Invasion on Survival and Recurrence in Patients with Resected Pancreatic Cancer
Jun-Feng Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
Y. Iwagami et al.
BRITISH JOURNAL OF CANCER (2013)
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - A retrospective tumor marker prognostic study
Marius Distler et al.
INTERNATIONAL JOURNAL OF SURGERY (2013)
Knockdown of the β1 integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis
John J. Grzesiak et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
CUB Domain-Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
Yuri Miyazawa et al.
CANCER RESEARCH (2010)
Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
A. Van den Broeck et al.
EJSO (2009)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Curative resection is the single most important factor determing outcome in patients with pancreatic adenocarcinoma
M Wagner et al.
BRITISH JOURNAL OF SURGERY (2004)
Share Paper
